These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 37387737)

  • 1. Retracted: Association between Mutation in SMARCAD1 and Basan Syndrome with Cutaneous Squamous Cell Carcinoma.
    Markers D
    Dis Markers; 2023; 2023():9813418. PubMed ID: 37387737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between Mutation in SMARCAD1 and Basan Syndrome with Cutaneous Squamous Cell Carcinoma.
    Xiong Y; Chen T; Yu J; Zhou H; Lu B; Chen L; Sun L; Wang C; Li S; Wu B
    Dis Markers; 2022; 2022():7840710. PubMed ID: 35592705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of two candidate genes for Basan syndrome.
    Marks KC; Banks WR; Cunningham D; Witman PM; Herman GE
    Am J Med Genet A; 2014 May; 164A(5):1188-91. PubMed ID: 24664640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two
    Elhaji Y; van Henten TMA; Ruivenkamp CAL; Nightingale M; Santen GW; Vos LE; Hull PR
    JID Innov; 2021 Sep; 1(3):100022. PubMed ID: 34909722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide linkage analysis and whole-genome sequencing identify a recurrent SMARCAD1 variant in a unique Chinese family with Basan syndrome.
    Li M; Wang J; Li Z; Zhang J; Ni C; Cheng R; Yao Z
    Eur J Hum Genet; 2016 Aug; 24(9):1367-70. PubMed ID: 26932190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Huriez syndrome: Additional pathogenic variants supporting allelism to SMARCAD syndrome.
    Loh AYT; Špoljar S; Neo GYW; Escande-Beillard N; Leushacke M; Luijten MNH; Venkatesh B; Bonnard C; van Steensel MAM; Hamm H; Carmichael A; Rajan N; Carney TJ; Reversade B
    Am J Med Genet A; 2022 Jun; 188(6):1752-1760. PubMed ID: 35212137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ectodermal dysplasia with congenital adermatoglyphia (Basan syndrome): Report of two cases presenting with extensive congenital milia.
    Nieto-Benito LM; Molina-López I; Feito-Rodríguez M; Martínez-González V; Suárez-Fernández R; Campos-Dominguez M
    Pediatr Dermatol; 2021 Mar; 38(2):530-532. PubMed ID: 33486784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Retracted] MicroRNA‑451a prevents cutaneous squamous cell carcinoma progression via the 3‑phosphoinositide‑dependent protein kinase‑1‑mediated PI3K/AKT signaling pathway.
    Fu J; Zhao J; Zhang H; Fan X; Geng W; Qiao S
    Exp Ther Med; 2024 Jul; 28(1):280. PubMed ID: 38800047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retracted: Multiomics Immune-Related lncRNA Analysis of Oral Squamous Cell Carcinoma and Its Correlation with Prognosis.
    Markers D
    Dis Markers; 2023; 2023():9861260. PubMed ID: 37387768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retracted: Fibroblast Growth Factor 3 Is Associated with Tongue Squamous Cell Carcinoma: A Controlled Study.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9784949. PubMed ID: 37503431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retracted: Biogenic Analysis of the Effect of TERC on Cell Proliferation and Migration of Oral Squamous Cell Carcinoma under Digital Minimally Invasive Treatment.
    International BR
    Biomed Res Int; 2023; 2023():9798465. PubMed ID: 37388366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retracted: Expression of Dickkopf-1 and Twist2 in Cervical Squamous Cell Carcinoma and Their Correlation with Vasculogenic Mimicry.
    Healthcare Engineering JO
    J Healthc Eng; 2023; 2023():9817429. PubMed ID: 37621628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retracted: Comprehensive and Integrated Analysis Identifies ZEB1 as a Key Novel Gene in Oral Squamous Cell Carcinoma.
    Imaging CMM
    Contrast Media Mol Imaging; 2023; 2023():9783040. PubMed ID: 37502536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retracted: Identification of Clinical Prognostic Regulators and Analysis of Ferroptosis-Related Signatures in the Tumor Immune Microenvironment in Lung Squamous Cell Carcinoma.
    Markers D
    Dis Markers; 2023; 2023():9893453. PubMed ID: 37387739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retracted: Establishment and Analysis of Hypoxia-Related Model in Oral Squamous Cell Carcinoma.
    Healthcare Engineering JO
    J Healthc Eng; 2023; 2023():9898076. PubMed ID: 37860331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retracted: IL-32 Promotes the Radiosensitivity of Esophageal Squamous Cell Carcinoma Cell through STAT3 Pathway.
    International BR
    Biomed Res Int; 2024; 2024():9796319. PubMed ID: 38229987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retracted: Identification of Gene-Tyrosine Kinase 2 (TYK2) in Head and Neck Squamous Cell Carcinoma Patients-An Integrated Bioinformatics Approach.
    Markers D
    Dis Markers; 2023; 2023():9836354. PubMed ID: 37744889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retracted: Identification of Novel Biomarkers Related to Lung Squamous Cell Carcinoma Using Integrated Bioinformatics Analysis.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9780526. PubMed ID: 38094439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retracted: Identification of Differentially Expressed Long Noncoding RNAs as Functional Biomarkers and Construction of Function Enrichment Network in Oral Squamous Cell Carcinoma.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9820845. PubMed ID: 37565232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retracted: Identification of Oxidative Stress-Associated Molecular Subtypes and Signature for Predicting Survival Outcome of Cervical Squamous Cell Carcinoma.
    Longevity OMAC
    Oxid Med Cell Longev; 2023; 2023():9795318. PubMed ID: 37565171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.